By Memorandum Opinion entered by The Honorable Colm F. Connolly in Pharmacyclics LLC et al. v. Alvogen Pine Brook LLC et al., Civil Action No. 19-0434-CFC-CJB (D.Del. August 19,
Continue Reading Chief Judge Connolly Issues Comprehensive Opinion Setting Forth Court’s Findings of Fact and Conclusions of Law on Infringement Claims and Invalidity Defenses as to Patents-in-Suit Following ANDA Trial

By Opinion entered by The Honorable Leonard P. Stark in Idenix Pharmaceuticals LLC et al. v. Gilead Sciences, Inc., Civil Action No. 14-846-LPS (D.Del. February 16, 2018), the District
Continue Reading Chief Judge Stark Grants Defendant’s Renewed JMOL Motion After Finding Patent-in-Suit Invalid for Lack of Enablement

By Memorandum Opinion entered by The Honorable Leonard P. Stark in Enzo v. Gen-Probe Inc., Civil Action No. 12-104-LPS (consolidated) (D.Del., June 28, 2017), the Court granted the motion
Continue Reading Chief Judge Stark Grants Defendants’ Motion for Summary Judgment of Invalidity of ‘180 Patent Based on Nonenablement

By Memorandum Opinion entered by The Honorable Leonard P. Stark in Fairchild Semiconductor Corp. v. Power Integrations, Inc., Civil Action No. 12-540-LPS (D.Del., May 4, 2015), the Court granted
Continue Reading Chief Judge Stark Grants Plaintiffs’ Motion for Summary Judgment in Part as to No Invalidity of Patent-in-Suit

By Memorandum Opinion entered by The Honorable Sue L. Robinson in Pi-Net International Inc. v. JPMorgan Chase & Co., Civil Action No. 12-282 SLR (D.Del., May 14, 2014), the
Continue Reading Judge Robinson Grants JP Morgan’s Motion for Summary Judgment of Invalidity of Patents-in-Suit

By Memorandum Opinion entered by The Honorable Sue L. Robinson in Intermec Technologies Corp. v. Palm Inc., Civil Action No. 07-272-SLR (D.Del., September 15, 2011), the Court granted Defendant

Continue Reading Judge Robinson Grants Palm’s and Intermec’s Motions For Summary Judgment on Invalidity and Infringement in Part

In Senju Pharmaceutical Co. Ltd., et al. v. Apotex Inc., et al., Civil Action No. 07-779-SLR, the U.S. District Court for the District of Delaware, by and through a memorandum opinion entered by The Honorable Sue L. Robinson on June 14, 2010, entered judgment in favor of defendants, Apotex Inc. and Apotex Corp. (“Apotex”), and against plaintiffs, Senju Pharmaceutical Co. Ltd (“Senju”), Kyorin Pharmaceutical Co. Ltd. (“Kyorin”) and Allergan, Inc. (“Allergan”). The case is an infringement action that was tried by bench trial on January 12-14, 2010. In rendering judgment in favor of defendants, the Court concluded among other things that, although plaintiffs had demonstrated by a preponderance of the evidence that defendants’ ANDA product infringed claims 1-3, 6,7, and 9 of the patent in dispute, U.S. Patent No. 6,333,045 (“the ‘045 patent”), defendants demonstrated by clear and convincing evidence that those claims are invalid based on obviousness given the asserted prior art. Id. at 15-21 and 37.

A complete copy of the Court’s Memorandum Opinion is attached.
 

Continue Reading Judge Robinson Enters Judgment in Favor of Defendants Apotex Upon Finding Patent Claims Invalid Based on Obviousness